The variant is rs6025 (Factor V Leiden mutation), found in both copies (homozygous) at high confidence: QUAL=228, DP=33, MQ=45. Factor V Leiden changes the shape of a clotting protein so the body's natural anticoagulant cannot switch it off properly. With two copies, this failure to brake is essentially complete rather than partial.

Practical checklist: (1) Every surgeon, anaesthetist, and gynaecologist needs to know. (2) For surgery or hospital stays, injections that thin the blood during recovery are typically recommended — this should be arranged in advance. (3) Long-haul flights: move every 1–2 hours, stay well hydrated, and ask your doctor whether a compression stocking would be appropriate. (4) If pregnancy is ever planned, consult a blood specialist before conception — anticoagulant treatment during pregnancy is usually recommended. (5) First-degree relatives (siblings, adult children) should be offered testing, as they may carry one copy.

The reassuring cross-reference from your blood test: homocysteine (7.82 µmol/L) is completely normal. Elevated homocysteine is a separate blood clot risk factor — the fact that it is normal means the MTHFR gene variant is not compounding this clotting picture at all.

The variant is rs1805129 (CHEK2 c.470T>C, p.Ile157Thr), heterozygous (one copy), QUAL=222, DP=63, MQ=47 — a high-quality call. CHEK2 is a "moderate penetrance" gene — unlike BRCA1 and BRCA2, it shifts odds moderately rather than dramatically.

What "personalised screening" means in practice: standard mammography in India typically begins at 45–50. For someone with a moderate-penetrance gene variant and early-onset maternal history, guidelines generally suggest starting earlier (35–40) and potentially adding MRI scans alongside mammography. MRI is significantly more sensitive for dense breast tissue, which is common in younger women. A breast specialist can calculate a formal risk score using validated tools and recommend a specific schedule.

A dedicated hereditary cancer gene panel (a separate, targeted DNA test specifically designed to classify breast cancer gene variants) would give a more precise classification of this finding than a general DNA analysis. This is worth considering but not urgent — it would primarily refine whether the specific variant in your DNA is definitively pathogenic, which narrows the risk estimate further.

The PCSK9 variant rs505151 was found in both copies (homozygous) at QUAL=228, DP=77, MQ=45 — high confidence. PCSK9 degrades LDL receptors on liver cells. With both copies carrying this variant, the impairment of LDL clearance is not partial — both sets of instructions are compromised.

Dietary changes that reliably lower LDL: reduce saturated fat (found in red meat, full-fat dairy, coconut oil, palm oil, fried food) and replace it with unsaturated fats (olive oil, nuts, avocado, oily fish like salmon, sardines, mackerel). Increase soluble fibre — found in oats, lentils, chickpeas, kidney beans, apples, and barley — which reduces LDL by binding cholesterol in the gut. Each change typically produces a 5–10% LDL reduction when done consistently. Regular aerobic exercise of 30+ minutes most days raises HDL and supports the full lipid picture.

PCSK9 inhibitors are an injectable class of cholesterol medication named after this very gene. They are highly effective for people with PCSK9 gain-of-function variants and can also lower Lp(a). Whether medication is appropriate is a conversation between you and your doctor based on your full risk picture, including the Lp(a) result once measured.

The IL-6 gene variant rs1800795 was found in both copies (homozygous) at QUAL=174, DP=13 — the lower depth of coverage is acceptable for a homozygous call. IL-6 drives the acute phase inflammatory response, and the promoter variant tends to produce slightly more IL-6 at baseline. This shifts chronic CRP modestly upward — useful context if a future resting CRP comes back between 2 and 5 mg/L.

The 2026 American Heart Association guidelines use a chronic baseline CRP of 2 mg/L as a cardiovascular risk threshold — below which is low risk, above which is an enhancer of cardiovascular risk. These thresholds are specifically for stable resting readings, not acute episodes like the one this result likely reflects.

Lifestyle factors that reliably reduce chronic CRP: regular moderate aerobic exercise, maintaining a healthy weight, prioritising 7–8 hours of sleep, a Mediterranean-style diet (vegetables, legumes, olive oil, oily fish, limited red meat and ultra-processed food), and eliminating smoking. Gum disease is a surprisingly common driver of persistently elevated CRP that many people overlook — worth a dental check.

The LPA variant rs1853021 was found in both copies (homozygous) at QUAL=228, DP=72, MQ=39. The slightly lower mapping quality at this position is a known characteristic of the LPA gene region — not a pipeline error. This is a regulatory variant that influences how much Lp(a) the liver produces; it would not appear in standard hereditary disease panels, and its absence from such reports is expected.

If Lp(a) comes back elevated (above 50 mg/dL or 125 nmol/L): injectable PCSK9 inhibitor medications lower both LDL and Lp(a). Low-dose aspirin has a modest Lp(a)-lowering effect. New Lp(a)-specific treatments are in late-stage clinical trials. An elevated result would also significantly strengthen the case for bringing LDL below 100 mg/dL through medication, as the two risks compound each other.

Iron is used for energy metabolism and thyroid function at the cellular level, even before haemoglobin falls. Ferritin below 20–30 ng/mL can cause fatigue, impaired exercise capacity, and hair shedding with a perfectly normal blood count — sometimes called "iron deficiency without anaemia." As menstrual patterns shift in perimenopause, iron balance can change in either direction.

Iron from animal sources (red meat, poultry, fish) is absorbed most efficiently. Plant sources (lentils, spinach, chickpeas, pumpkin seeds) provide iron but need Vitamin C alongside for best absorption — for example, a squeeze of lemon with a lentil dish. Tea and coffee consumed around mealtimes reduce iron absorption significantly.

CETP rs5882 was found heterozygous (one copy) at QUAL=222, DP=109, MQ=47. HDL below 50 mg/dL in women is classified as a cardiovascular risk factor in the 2026 AHA guidelines. When combined with LDL 131 and ApoB 107, the overall lipid picture is more significant than any single number suggests. Your ApoB/ApoA1 ratio of 0.71 falls in the "average risk" category — providing some reassurance that the imbalance is not extreme.

ABCC8 rs757110 was found heterozygous (one copy) at QUAL=222, DP=70, MQ=47 — high quality. ABCC8 encodes SUR1, a component of the pancreatic beta-cell potassium channel. The risk allele modestly impairs glucose-stimulated insulin release. One copy produces a smaller effect than two would. HbA1c at 5.6% is the top of the normal range — one decimal below the 5.7% pre-diabetes threshold. The combination of fully normal fasting glucose and HbA1c at 5.6% is reassuring.

Perimenopause is associated with progressive changes in insulin sensitivity — oestrogen has a protective metabolic effect, and as levels fluctuate some women see blood sugar metrics drift. Annual monitoring for the next 5–10 years is particularly valuable for this reason.